Prohibit health insurers from performing prior authorization on psychiatric drugs in shortage or discontinued
SB 317 prohibits health insurance companies from requiring prior authorization for psychiatric prescription drugs that are officially designated as being in shortage. The list of these drugs will be updated quarterly, based on the U.S. Food and Drug Administration's official shortage list. This aims to ensure covered persons can access necessary psychiatric medications without delays due to prior authorization when supplies are limited. Additionally, the bill prevents manufacturers of these shortage drugs from engaging in predatory pricing or marketing practices.
Bill status
signed
all 5 stages cleared
Introduction
Feb 2025
Committee Review
Apr 2025
Senate Passage
Apr 2025
House Passage
Apr 2025
Signed into Law
May 2025
Introduced Feb 13, 2025
Signed May 13, 2025
Maddy AI version diff · 3 comparisons
What changed between versions
SB0317_2(10).pdf
→
SB0317_X.pdf
·
3 edits
MINOR
The bill was finalized and enrolled, changing its status from a draft to an official enacted law. The core policy remains the prohibition of prior authorization for psychiatric drugs in shortage or discontinued status, but the text was cleaned up to remove redundant titles and formatting errors found in the earlier version.
Scope change
The scope of the bill's application remains unchanged; it continues to apply to health insurance issuers and prescription drugs designated as in shortage by the FDA within the psychiatric category.
TECHNICAL
Removed redundant and conflicting title text that appeared in the draft version, clarifying the bill's purpose in the header.
Corrected formatting inconsistencies, such as removing unnecessary line breaks and standardizing the layout of the act title and section headers.
TIMELINE
Added certification signatures and dates for the Senate Secretary, President, and House Speaker, indicating the bill has passed all legislative stages and is now official.
Floor votes · Senate Mar 5, 2025 · House Apr 11, 2025
How they voted
49–1
Passed
Total votes 50
Mar 5, 2025
D
Democratic18
100% Yea
R
Republican32
96% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
43
Key actions
9
Committee
6
May 9, 2025
Signed into law
(S) Signed by Governor
upper
Apr 29, 2025
Lower · Passed
(H) Signed by Speaker
lower
Apr 21, 2025
Upper · Passed
(S) Signed by President
upper
Apr 11, 2025
House · Passed
House Vote: pass (98-1-1)
house
Apr 8, 2025
Lower · Passed
(H) Committee Report - (H) Business and Labor
lower
Apr 8, 2025
Lower · Passed
(H) Committee Executive Action - (H) Business and Labor
lower
Mar 5, 2025
Senate · Passed
Senate Vote: pass (49-1)
senate
Mar 5, 2025
Committee
(H) Referred to Committee - (H) Business and Labor
lower
Mar 1, 2025
Upper · Passed
(S) Committee Report - (S) Public Health, Welfare and Safety
upper
Mar 1, 2025
Upper · Passed
(S) Committee Executive Action - (S) Public Health, Welfare and Safety
upper
Feb 14, 2025
Committee
(S) Referred to Committee - (S) Public Health, Welfare and Safety
upper
Feb 13, 2025
Introduced
(S) Introduced
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Dennis Lenz
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 317
Scope: MT
Hi! I can help you understand SB 317. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline